BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 28136133)

  • 1. The gastrointestinal tract: properties and role in allogeneic hematopoietic stem cell transplantation.
    Pessach I; Tsirigotis P; Nagler A
    Expert Rev Hematol; 2017 Apr; 10(4):315-326. PubMed ID: 28136133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal microbiota-related effects on graft-versus-host disease.
    Shono Y; Docampo MD; Peled JU; Perobelli SM; Jenq RR
    Int J Hematol; 2015 May; 101(5):428-37. PubMed ID: 25812838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal Microbiota Influence Immune Tolerance Post Allogeneic Hematopoietic Cell Transplantation and Intestinal GVHD.
    Köhler N; Zeiser R
    Front Immunol; 2018; 9():3179. PubMed ID: 30705680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between acute graft-versus-host disease and antimicrobial peptide expression in the gastrointestinal tract after allogeneic stem cell transplantation.
    Weber D; Frauenschläger K; Ghimire S; Peter K; Panzer I; Hiergeist A; Weber M; Kutny D; Wolff D; Grube M; Huber E; Oefner P; Gessner A; Hehlgans T; Herr W; Holler E
    PLoS One; 2017; 12(9):e0185265. PubMed ID: 28934349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The primacy of gastrointestinal tract antigen-presenting cells in lethal graft-versus-host disease.
    Koyama M; Hill GR
    Blood; 2019 Dec; 134(24):2139-2148. PubMed ID: 31697827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Insights Into the Mechanism of GVHD-Induced Tissue Damage.
    Ara T; Hashimoto D
    Front Immunol; 2021; 12():713631. PubMed ID: 34512636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Promising Insight: The Potential Influence and Therapeutic Value of the Gut Microbiota in GI GVHD.
    Li J; Zhang X; Chen Y; Zheng Q; Zhao M; Jiang H
    Oxid Med Cell Longev; 2022; 2022():2124627. PubMed ID: 35571252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of GVHD on the gut and intestinal microflora.
    Ji H; Feng S; Liu Y; Cao Y; Lou H; Li Z
    Transpl Immunol; 2024 Feb; 82():101977. PubMed ID: 38184214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Toll-Like Receptor Signaling in the Pathogenesis of Graft-versus-Host Diseases.
    Tu S; Zhong D; Xie W; Huang W; Jiang Y; Li Y
    Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27529218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal microbiota transplantation in the treatment of intestinal steroid-resistant graft-versus-host disease: two case reports and a review of the literature.
    Biernat MM; Urbaniak-Kujda D; Dybko J; Kapelko-Słowik K; Prajs I; Wróbel T
    J Int Med Res; 2020 Jun; 48(6):300060520925693. PubMed ID: 32527171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the intestinal mucosa in acute gastrointestinal GVHD.
    Peled JU; Hanash AM; Jenq RR
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):119-127. PubMed ID: 27913470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the intestinal mucosa in acute gastrointestinal GVHD.
    Peled JU; Hanash AM; Jenq RR
    Blood; 2016 Nov; 128(20):2395-2402. PubMed ID: 27856471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low percentages of circulating CD8(+)/CD45RA(+) human T lymphocytes expressing beta7 integrin correlate with the occurrence of intestinal acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Avanzini MA; Maccario R; Locatelli F; Giebel S; Santos CD; Bernardo ME; Pagliara D; Montagna D; Longo S; Amendola G; Marconi M
    Exp Hematol; 2006 Oct; 34(10):1429-34. PubMed ID: 16982336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute Graft-versus-Host Disease: Novel Biological Insights.
    Teshima T; Reddy P; Zeiser R
    Biol Blood Marrow Transplant; 2016 Jan; 22(1):11-6. PubMed ID: 26453971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of microbiota in allogeneic hematopoietic stem cell transplantation.
    Chang CC; Hayase E; Jenq RR
    Expert Opin Biol Ther; 2021 Aug; 21(8):1121-1131. PubMed ID: 33412949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical role of the gut microbiome and fecal microbiota transplantation in allogeneic stem cell transplantation.
    Henig I; Yehudai-Ofir D; Zuckerman T
    Haematologica; 2021 Apr; 106(4):933-946. PubMed ID: 33241674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Key players in intestinal GVHD].
    Hashimoto D; Teshima T
    Rinsho Ketsueki; 2015 Jul; 56(7):807-14. PubMed ID: 26251143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colonoscopy in the diagnosis of intestinal graft versus host disease and cytomegalovirus enteritis following allogeneic haematopoietic stem cell transplantation.
    He JD; Liu YL; Wang ZF; Liu DH; Chen H; Chen YH
    Chin Med J (Engl); 2008 Jul; 121(14):1285-9. PubMed ID: 18713549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The gut mucosa barrier is preserved during allogeneic, haemopoietic stem cell transplantation with reduced intensity conditioning.
    Johansson JE; Brune M; Ekman T
    Bone Marrow Transplant; 2001 Oct; 28(8):737-42. PubMed ID: 11781624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.